Author Correction To: Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson’s Disease

CNS Drugs - United Kingdom
doi 10.1007/s40263-018-0510-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson’s Disease (EASE LID 2 Study): Interim Results of an Open-Label Safety Study

Journal of Parkinson's Disease
Molecular NeuroscienceNeurologyCellular
2017English

Cardinal Motor Features of Parkinson’s Disease Coexist With Peak-Dose Choreic-Type Drug-Induced Dyskinesia: Parkinson’s Symptoms Coexist With Dyskinesia

Journal of Parkinson's Disease
Molecular NeuroscienceNeurologyCellular
2018English

Effects of Renal Impairment on the Pharmacokinetics of Once-Daily Amantadine Extended-Release Tablets

CNS Drugs
PsychiatryMental HealthNeurologyPharmacology
2019English

Pooled Baseline Characteristics of Women in Phase III Benralizumab Asthma Exacerbation Studies (SIROCCO and CALIMA)

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Conversion From Twice-Daily Tacrolimus Capsules to Once-Daily Extended-Release Tacrolimus (LCPT)

Transplantation
Transplantation
2013English

Efficacy of Venlafaxine Extended-Release Capsules in Nondepressed Outpatients With Generalized Anxiety Disorder

JAMA - Journal of the American Medical Association
Medicine
2000English

Sensitivity of EQ-5D to Clinical Change in Patients With Parkinson’s Disease L-Dopa Induced Dyskinesia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Author Correction: Multimodal Imaging Analyses in Patients With Genetic and Sporadic Forms of Small Vessel Disease

Scientific Reports
Multidisciplinary
2019English

Dyskinesia-Hyperpyrexia Syndrome in a Patient With Parkinson’s Disease: A Case Report

Clinical Neurology
Neurology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy